Sibutramine on Cardiovascular Outcome

May 2011
Diabetes Care;May2011 Supplement 2, Vol. 34, pS114
Academic Journal
The article offers a discussion on the perceived cardiovascular disease (CVD) risks of sibutramine and cardiovascular outcomes in overweight/obese patients with or without type 2 diabetes. Considered effective in managing obese patients, sibutramine improves insulin resistance markers, glucose metabolism and atherogenic dyslipidemia. Some side effects of the drug include hypretension, tachycardia, arrhythmias and myocardial infarction. The primary composite outcomes include nonfatal myocardial infarction and rescucitated cardiac arrest.


Related Articles

  • A Study of Microalbuminuria and Target Organ Damage in Patients with Essential Hypertension. Badiger, Sharan; H. M., Sandeep; Talikoti, Satish C.; M. S., Biradar // International Journal of Biological & Medical Research;2012, Vol. 3 Issue 1, p1351 

    Hypertension usually associated with other cardiovascular risk factors such as age, overweight, diabetes, insulin resistance and dyslipidemia. The target organ damage such as left ventricular hypertrophy, microalbuminuria, acute coronary syndrome, stroke and cognitive dysfunction takes place...

  • Differentiation of obese patients at moderate or higher Findrisc score based on their atherogenic index. Andreeva-Gateva, Pavlina A.; Konsulova, Petya; Orbetzova, Maria; Georgieva-Nikolova, Radka; Tafradjiiska-Hadjiolova, Radka; Angelova, Violina; Voynikov, Yulian; Nikolova, Irina; Simova, Iscra // Postgraduate Medicine;Nov2016, Vol. 128 Issue 8, p790 

    Objectives: The purpose of this study was to reveal different subgroups of patients with at least moderate risk of developing diabetes in the next 10 years, based on clustering of cardiovascular risk factors.Methods: We performed a one-center cross-sectional study of...

  • Nontraditional cardiovascular risk factors common in overweight black youth.  // Infectious Diseases in Children;Dec2010, Vol. 23 Issue 12, p29 

    The article discusses a study which noted the use of unconventional risk factors to identify the development of cardiovascular disease in overweight and obese black adolescents.

  • APPLE TURNOVER.  // Shape;Jul2011, Vol. 30 Issue 11, p92 

    The article discusses a study in the journal “Lancet” that negates the idea that people who carry more fat around their waist are more prone to have a heart attack or stroke, and offers comments from cardiologist Sarah Samaan on the subject.

  • Sibutramine: suspension of sales.  // WHO Drug Information;2010, Vol. 24 Issue 4, p307 

    The article reports on a 2010 regulatory decision which Singapore's Health Sciences Authority made to suspend the sales of sibutramine products following a benefit risk assessment which took the findings from the Sibutramine Cardiovascular Outcomes study into consideration.

  • The Association of Calcium Intake and Other Risk Factors with Cardiovascular Disease among Obese Adults in USA. Yang Chen; Strasser, Sheryl; Callahan, Katie; Blackley, David; Yan Cao; Liang Wang; Shimin Zheng // Advance Journal of Food Science & Technology;2014, Vol. 6 Issue 3, p333 

    In this study, we used a cross-sectional study design to examine the relationship between the calcium intake and risk factors for CVD among obese adults by using continuous waves of National Health and Nutrition Examination Survey (NHANES) data 1999-2010. The association between calcium intake...

  • Prevalencia de sobrepeso y obesidad en adultos españoles. Rodríguez-Rodríguez, E.; López-Plaza, B.; López-Sobaler, A. Ma.; Ortega, R. Ma. // Nutricion Hospitalaria;mar/abr2011, Vol. 26 Issue 2, p355 

    Aim: to assess the prevalence of excess weight and obesity in Spanish adults and to know the current situation and its evolution in the last years. Material and methods: The study involved 418 subjects (196 men and 222 women) from 18 to 60 years, who were selected to constitute a representative...

  • Subclinical Hypothyroidism as a Risk Factor for the Development of Cardiovascular Disease in Obese Adolescents With Nonalcoholic Fatty Liver Disease. Sert, Ahmet; Pirgon, Ozgur; Aypar, Ebru; Yilmaz, Hakan; Odabas, Dursun // Pediatric Cardiology;Jun2013, Vol. 34 Issue 5, p1166 

    No data are available on the relationship between subclinical hypothyroidism and risk factors for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease (NAFLD). This study aimed to determine whether an association exists between subclinical...

  • Weight loss fails to cut diabetes CV risk.  // Pulse;Aug2013, p15 

    The article reports on the clinical trial conducted by the U.S. researchers which reveals that overweight diabetic patients who reduce weight through diet and exercise has no significant improvements in the reduction of risk in the cardiovascular (CV) disease.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics